What are GLP-1 Drugs?
- GLP-1 drugs are medications known as GLP-1 receptor agonists, used primarily for managing Type 2 diabetes and obesity.
- They mimic the action of the naturally occurring GLP-1 hormone, which is released by the intestine after food intake.
- They regulate blood glucose levels, suppress appetite and promote weight loss.
How Do GLP-1 Drugs Work?
- Stimulate insulin secretion: Promote insulin release from the pancreas in response to elevated blood glucose.
- Suppress glucagon: Reduce glucagon secretion, limiting excess glucose release by the liver.
- Slow gastric emptying: Delay the movement of food from the stomach into the intestine, increasing the feeling of fullness.
- Reduce appetite: Act on appetite-regulating pathways, helping reduce food intake and body weight.
Major GLP-1 Medications
| Drug | Important feature |
| Semaglutide | Available as injection and oral tablets |
| Liraglutide | GLP-1 receptor agonist |
| Dulaglutide | Long-acting GLP-1 receptor agonist |
| Exenatide | GLP-1 receptor agonist |
| Exenatide Extended Release | Long-acting formulation |
| Tirzepatide | Dual GIP and GLP-1 receptor agonist |
Regulation of GLP-1 Drugs in India
- Regulatory Authority: Central Drugs Standard Control Organisation (CDSCO), headed by the Drug Controller General of India (DCGI).
- Prescription Requirement: GLP-1 medicines are prescription-based drugs and should be used under qualified medical supervision.
- March 10, 2026 Advisory: DCGI issued an advisory to manufacturers against misleading advertisements and promotion encouraging non-prescription use.
- Regulatory Inspections: 49 businesses, including online pharmacy warehouses, wholesalers, retailers and weight-loss clinics, were inspected.
- Penalties: Violations may attract licence cancellation, fines and legal action under applicable laws.
Conclusion
GLP-1 drugs represent an important advancement in managing Type 2 diabetes and obesity. However, their growing popularity necessitates prescription-based access, patient awareness and effective pharmaceutical regulation to ensure safe and rational use.
| This Concept has been discussed in the following article: Retatrutide: A Novel Drug for Obesity and Osteoarthritis |